A small change to a powerful molecular tool — using the CRISPR-Cas13 enzyme, which can detect RNA from viruses and cells — ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was up +2.7% at $51.31. This move outpaced the S&P 500's daily gain of 0.54%. Elsewhere, the Dow saw an upswing of 1.05%, while the ...

The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.

Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer (TNBC) by combining CRISPR/Cas9 gene ...

GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests ...

PHILADELPHIA -- Inside a heated tent on the Children’s Hospital of Philadelphia campus, 17-month-old KJ Muldoon wiggled ...

The Life and Biodiversity Laboratory , announced by Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, ...

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

Health news and commentary gathered by MedPage Today staff ...

Colossal Biosciences is applying genetics and long-term biostorage to conservation efforts, with research also exploring ...

The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions ...

Over the next two years, the planned funding will be allocated to projects that have received some FDA feedback as well as emerging efforts.